Literature DB >> 18720309

Neurologic symptoms as a feature of the antiphospholipid syndrome.

Wolfgang Miesbach1.   

Abstract

Antiphospholipid antibodies may cause various neurologic diseases by vascular and immune mechanisms. Ischemic stroke and transient ischemic attacks are the most common neurologic complications in patients with antiphospholipid antibodies but migraine, epilepsy, chorea, or multiple sclerosis also may occur. Although the neurologic presentation of patients with the antiphospholipid syndrome may vary, many patients have striking similarities, such as initial memory loss, aphasia, cognitive dysfunction with progressive cerebral deterioration, and even dementia. In conclusion, antiphospholipid syndrome may constitute a treatable cause of neurologic diseases, and the measurement of antiphospholipid antibodies should be routinely performed in patients with neurologic disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720309     DOI: 10.1055/s-0028-1082273

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  5 in total

Review 1.  Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.

Authors:  Sarthak Gupta; Robert Zivadinov; Deepa Ramasamy; Julian L Ambrus
Journal:  Clin Rheumatol       Date:  2013-11-26       Impact factor: 2.980

Review 2.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

3.  Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay.

Authors:  Karl Egerer; Dirk Roggenbuck; Thomas Büttner; Barbara Lehmann; Annushka Kohn; Philipp von Landenberg; Rico Hiemann; Eugen Feist; Gerd-Rüdiger Burmester; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2011-07-21       Impact factor: 5.156

Review 4.  The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

Authors:  Emmanuel J Favaloro; Richard C W Wong
Journal:  Auto Immun Highlights       Date:  2010-07-10

Review 5.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.